Press Releases
HOUSTON, Aug. 20, 2019 /PRNewswire/ -- Millar, Inc., medical device manufacturer and
Read more...20 August 2019
AUSTIN, Texas, Aug. 20, 2019 /PRNewswire/ -- Today, IGNITE, an all-female, and veterinarian owned, company specializing in job role specific skills training for veterinary teams, and case-based training for veterinarians and veterinary students, announced that Phase II of their learning platform construction is nearing completion.
Read more...20 August 2019
PLYMOUTH MEETING, Pa., Aug. 20, 2019 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) has begun publishing updated versions of cancer care guidelines adapte
Read more...20 August 2019
MENLO PARK, Calif., Aug. 20, 2019 /PRNewswire/ -- Today Health2047 Inc. is launching Zing Health, a tech-enabled health plan for those who are underserved by existing insurance plans. Co-founded by Health2047 with e
Read more...20 August 2019
LOS ANGELES, Aug. 20, 2019 /PRNewswire/ -- Zynx Health™, market leader in providing evidence- and experience-based clinical improvement solutions since 1996, announced today the release
Read more...HOUSTON, Aug. 20, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced approval by the Emory University Clinical Trial Review Committee (CTRC) to move forward with an
Read more...LUND, Sweden, Aug. 20, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company will host a Capital Markets Day in Stockholm on 9 October, 2019, for investors, analysts and media.Presentations will be m
Read more...20 August 2019
BURLINGTON, ON, Aug. 20, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") announced today the co
Read more...20 August 2019
SMITHS FALLS, ON, Aug. 20, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED), (NYSE:
Read more...20 August 2019
OLDWICK, N.J., Aug. 20, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Sherron Kell, MD, MPH as Senior Vice President of Clinical Development. Dr. Kell will lead the PRV-031 (tepli
Read more...